The recombinant genes were expressed in the Escherichia coli expression host, BL21(DE3), harvested as inclusion bodies, extracted into a urea buffer and purified. The MHC-I heavy chain proteins were never exposed to reducing conditions. This allows purification of highly active preoxidized MHC-I heavy chains [[41]]. The proteins were identified by A280 Erlotinib order absorbance and SDS-PAGE, and concentrations were determined

by BCA assay (Pierce, Cat no. 23225). The degree of biotinylation (usually >95%) was determined by a gel-shift assay [[40]]. The preoxidized, denatured proteins were stored at −20°C in an 8 M urea buffer. Native, recombinant human β2m was expressed and purified as previously described [[41, 42]]. Briefly, a HAT followed by an FXa restriction enzyme site was inserted N-terminally of a synthetic gene encoding the native, mature human β2m. The recombinant gene was expressed in the E. coli expression host, BL21(DE3), harvested as inclusion bodies, extracted

into a urea buffer, folded by dilution and purified. The tagged β2m protein was digested for 48 h at room temperature with the FXa protease releasing intact natively Ceritinib folded β2m. The folded β2m was purified as previously described, and fractions containing β2m was identified by A280 UV absorbance and SDS-PAGE, and pooled. Protein concentrations were determined by BCA assay. The native β2m proteins were stored at −20°C. The recombinant β2m was radio-labeled with iodine (125I) using the chloramine-T procedure [[43]]. Twenty microgram of β2m was mixed with 1 mCi 125I and 5 μL chloramines-T (1 mg/mL) (Sigma, C9887, Sigma Alrich, Brondby, Denmark) for 1 min. The reaction

was stopped by adding 5 μL metabisulfite (1 mg/mL) (Sigma). Unreacted iodine was removed by gel filtration chromatography using a 1 mL Sephadex G10 column equilibrated in PBS. Column fractions of 200 μL were tested for radioactivity and the labeled fractions were identified. The radioactivity was measured on a gamma counter (Packard Cobra 5010) and Teicoplanin diluted to 25,000 cpm/μL in PBS containing 2% ethanol and 0.1% azide, and stored at 4°C. The measurement of pMHC-I stability was done as recently described [[14]]. Briefly, recombinant, biotinylated MHC-I heavy chain molecules in 8 M urea were diluted 100-fold into PBS buffer containing radiolabeled β2m and peptide to initiate pMHC-I complex formation. The reaction was carried out in streptavidin coated scintillation 384 (or 96) well microplates (Flashplate® PLUS, Perkin Elmer, Boston, USA).